Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Marc Espié"'
Autor:
Carole Mathelin, Emmanuel Barranger, Martine Boisserie-Lacroix, Gérard Boutet, Susie Brousse, Nathalie Chabbert-Buffet, Charles Coutant, Emile Daraï, Yann Delpech, Martha Duraes, Marc Espié, Luc Fornecker, François Golfier, Pascale Grosclaude, Anne Sophie Hamy, Edith Kermarrec, Vincent Lavoué, Massimo Lodi, Élisabeth Luporsi, Christine M. Maugard, Sébastien Molière, Jean-Yves Seror, Nicolas Taris, Catherine Uzan, Charlotte Vaysse, Xavier Fritel
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 50:107-120
Autor:
Gaëlle Douchet, Marc Espié
Publikováno v:
Soins. 64:56-59
Le traitement medical des cancers du sein s'est considerablement enrichi ces dernieres annees z Les indications therapeutiques ont ete affinees grâce a la classification moleculaire des cancers. La chimiotherapie restera encore pour quelques annees
Autor:
Pietrina Cottu, Christelle Jouannaud, N. Esposito, L. Dima-Martinez, Alain Lortholary, Chahinez Benkanoun, Marc Espié, V. Pottier, J-P. Spano, H. Attar-Rabia, P. Rivera, L. Moreau, Dominique Spaeth, Joseph Gligorov, Xavier Pivot, Jean-Marc Extra
Publikováno v:
European Journal of Cancer. 82:230-236
HannaH (NCT00950300) and PrefHer (NCT01401166) studies validated the subcutaneous (H-s.c.) formulation of trastuzumab as effective and safe as intravenous (H-i.v.) and highly preferred by patients in early breast cancer. The present randomised Metasp
Autor:
Cristina Saura, Matthew Wongchenko, SJ Isakoff, Rebecca Dent, Aruna Mani, N. Xu, Denise Bradley, Mafalda Oliveira, S-B Kim, S-J. Reilly, Antoinette R. Tan, S-A. Im, Marc Espié, S. Blau
Publikováno v:
Annals of Oncology. 31:S64-S65
Autor:
Ahmad Awada, Marc Espié, Miguel Martín, Mafalda Oliveira, Philippe Aftimos, Pilar Lardelli, Eva E.M. Fernández-García, Sonia Extremera, Javier Cortes, Sara López-Tarruella, Suzette Delaloge
Publikováno v:
Clinical Breast Cancer. 16:364-371
Background Preclinical and clinical data suggest that xeroderma pigmentosum G gene (XPG) status might predict trabectedin efficacy. This phase 2 study evaluated the efficacy of trabectedin at a dose of 1.3 mg/m 2 as a 3-hour intravenous infusion ever
Autor:
Marc Espié, Lina Bolotine, Jean-Charles Soria, Anne Laprie, Lucie Karayan-Tapon, Jocelyn Céraline, Henri Roché, Patricia de Cremoux, Jean-Jacques Mazeron, Sylvie Negrier, Gilles Calais, Gérard Bastian
Publikováno v:
Bulletin du Cancer. 103:719-729
Autor:
Marc Espié, Paul Blanc-Durand, Luca Campedel, Charlotte Gardair, L. Teixeira, A. De Roquancourt, Sylvie Giacchetti, J. Lehmann Che, Caroline Cuvier, A. Binasker, Stéphanie Bécourt, Florence Ledoux
Publikováno v:
Annals of Oncology. 30:v101-v102
Background Inflammatory breast cancers (IBC) particularly triple negative (TN) subtype have poor prognosis. Methods Between January 2010 and December 2016, all patients with TNIBC seen at breast cancer disease center, St Louis hospital, Paris, France
Autor:
Luis Augusto Teixeira, Christine Le Maignan, Marc Espié, Jérôme Cochereau, Sylvie Giacchetti, Sabrina Da Costa, Hélène Gauthier, Delphine Cochereau
Publikováno v:
Bulletin du Cancer. 103:444-454
Methotrexate represents the standard intrathecal treatment of breast cancer meningeal carcinomatosis. However, its optimal schedule remains undefined. The aim of the present study was to evaluate results obtained with the methotrexate schedule used i
Autor:
Sarah Eskenazi, H. Hocini, Bertrand Tournant, Sylvie Giacchetti, Raphaël Porcher, Anne-Sophie Hamy, F. Perret, Caroline Cuvier, Marc Espié, Florence Coussy, S. Bonfils, Patrick Charveriat, Jean-Marc Lacorte
Publikováno v:
Reproductive BioMedicine Online. 32:299-307
Few studies have reported reproductive outcomes after breast cancer chemotherapy. The relationship between anti-Müllerian hormone (AMH) concentrations and the occurrence of subsequent pregnancies in women after chemotherapy for breast cancer was inv
Autor:
F. Maxwell, P. Bourrier, C. de Bazelaire, M. Albiter, M Chapelier, E. de Kerviler, Marc Espié, E. Cauderlier, C. de Margerie Mellon, M. Bricout
Publikováno v:
Diagnostic and Interventional Imaging. 96(10):1089-1101
The nodal status in breast cancer is a major prognostic factor in terms of survival. It also plays a role in the therapeutic decision-making process. Therefore, the evaluation of lymph node involvement in breast cancer is imperative in establishing a